3
Announcements
Trials
Browse
Landscape
Status
Recruiting
4
Not yet recruiting
2
Completed
2
Terminated
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor
Interventions
tucatinib
1
talquetamab
1
niraparib
1
futibatinib
1
erdafitinib
1
cemiplimab
1
amivantamab
1
adagrasib
1
Trastuzumab
1
TIC10 compound
1
Prednisone
1
Prednisolone
1
Capecitabine
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Approved for marketing
×
trilaciclib
×
1 year
×
Clear all
No trials found.